Showing 21 - 40 results of 515 for search '(( greater decrease ) OR ((((( liver increase ) OR ( master decrease ))) OR ( less decrease ))))*', query time: 0.13s Refine Results
  1. 21
  2. 22
  3. 23

    Chemotherapy prior to Hepatic Resection for Colorectal Liver Metastases: Helpful until Harmful? by Abdalla, Eddie K.

    Published 2009
    “…Steatohepatitis is associated with irinotecan therapy and an increased risk for liver failure and death after hepatic resection. …”
    Get full text
    Get full text
    Get full text
    article
  4. 24

    Systemic Chemotherapy and Two-Stage Hepatectomy for Extensive Bilateral Colorectal Liver Metastases by Chun, Yun Shin

    Published 2007
    “…Background Two-stage hepatectomy has been proposed for patients with bilateral colorectal liver metastases (CLM). The aim of this study was to compare the outcome of patients with CLM treated with preoperative chemotherapy followed by one- or two-stage hepatectomy. …”
    Get full text
    Get full text
    Get full text
    article
  5. 25

    Novel biomarkers for potential risk stratification of drug induced liver injury (DILI) by Mohammed Ibn-Mas’ud Danjuma (13192169)

    Published 2019
    “…<h3>Background:</h3><p dir="ltr">Drug induced liver injury (DILI) is an increasing cause of acute liver injury especially with increasing need for pharmacotherapy of widening comorbidities amongst our ever-aging population. …”
  6. 26

    Noncoding RNAs in Nonalcoholic Fatty Liver Disease: Potential Diagnosis and Prognosis Biomarkers by Olfa Khalifa (10914452)

    Published 2020
    “…<p>Nonalcoholic fatty liver disease (NAFLD) is currently the most common chronic liver disease worldwide in part due to the concomitant obesity pandemic and insulin resistance (IR). …”
  7. 27
  8. 28

    Deep learning-based modeling of land use/land cover changes impact on land surface temperature in Greater Amman Municipality, Jordan (1980–2030) by Khaled F. Alkaraki (22051967)

    Published 2024
    “…This study aimed to model past, present, and future LULCC on Land Surface Temperatures in the Greater Amman Municipality (GAM) in Jordan between 1980 and 2030. …”
  9. 29

    Effectiveness of Positron Emission Tomography for Predicting Chemotherapy Response in Colorectal Cancer Liver Metastases by Glazer, Evan

    Published 2010
    “…Transcutaneous ultrasonography is even less invasive but often less accurate.9 Finally, positron emission tomography (PET) using fluorine-18–labeled deoxyglucose detects increased metabolic activity (uptake). …”
    Get full text
    Get full text
    Get full text
    article
  10. 30
  11. 31

    A marking technique for intraoperative localization of small liver metastases before systemic chemotherapy by Zalinski, Stephanie

    Published 2009
    “…Preoperative chemotherapy is increasingly used prior to resection of colorectal liver metastases (CLM). …”
    Get full text
    Get full text
    Get full text
    article
  12. 32

    Repeat hepatectomy for recurrent colorectal liver metastases is associated with a high survival rate by Andreou, Andreas

    Published 2011
    “…Background:  The outcome after a repeat hepatectomy for recurrent colorectal liver metastases (CLM) is not well defined. The present study examined the morbidity, mortality and long-term survivals after a repeat hepatectomy for recurrent CLM. …”
    Get full text
    Get full text
    Get full text
    article
  13. 33

    Body surface area and body weight predict total liver volume in Western adults by Vauthey, Jean-Nicolas

    Published 2002
    “…Computed tomography (CT) is used increasingly to measure liver volume in patients undergoing evaluation for transplantation or resection. …”
    Get full text
    Get full text
    Get full text
    article
  14. 34

    Artificial Intelligence for Detecting and Quantifying Fatty Liver in Ultrasound Images: A Systematic Review by Fahad Muflih Alshagathrh (18427950)

    Published 2022
    “…Conclusion: AI-supported systems show potential performance increases in detecting and quantifying steatosis, NASH, and liver fibrosis in NAFLD patients. …”
  15. 35

    Impaired Liver Size and Compromised Neurobehavioral Activity are Elicited by Chitosan Nanoparticles in the Zebrafish Embryo Model by Haissam Abou-Saleh (497840)

    Published 2019
    “…Although no single sign of cardiotoxicity was observed upon exposure to 200 mg/L of ChNPs, as judged by heartbeat rate, the corrected QT interval (QTc, which measures the time between the start of the Q wave and the end of the T wave in the heart's electrical cycle), maximum cardiac arrest, and ejection fraction assays, the same dosage elicited the impairment of both liver size (decreased liver size, but without steatosis and lipid yolk retention) and neurobehavioral activity (increased movement under different light conditions). …”
  16. 36

    Assessment of tropospheric NO<sub>2</sub> concentrations over greater Doha using Sentinel-5 TROPOspheric monitoring instrument (TROPOMI) satellite data: Temporal analysis, 2018–202... by Yasir E. Mohieldeen (22155901)

    Published 2024
    “…<p dir="ltr">This study presents a temporal evaluation of the tropospheric NO<sub>2</sub> column densities over Greater Doha using TROPOMI satellite data from May 2018 to December 2023, and an assessment of the impact of the preparations and hosting of the FIFA Football World Cup Qatar 2022, on NO<sub>2</sub> levels before, during and after the tournament over Greater Doha. …”
  17. 37

    Effects of lipid administration on liver apoptotic signals in a mouse model of total parenteral nutrition (TPN) by Btaiche, Imad

    Published 2004
    “…Interestingly, we have recently observed an increase in hepatocyte apoptosis with administration of TPN. …”
    Get full text
    Get full text
    Get full text
    Get full text
    article
  18. 38

    Efficacy and safety of aldafermin in non-alcoholic steatohepatitis: A systematic review and meta-analysis of randomized controlled trials by Mohamed Mahmoud Marey (18560902)

    Published 2024
    “…<h3>Background</h3><p dir="ltr">Non-alcoholic steatohepatitis (NASH) is an advanced subtype of non-alcoholic fatty liver disease (NAFLD). NASH prevalence is increasing exponentially and carries a high risk for disease progression, cirrhosis, and liver-related mortality. …”
  19. 39

    Novel proteins implicated in lipid metabolism disorders by Nature Research (16552612)

    Published 2016
    “…</p><p>ANGPTL3 is a protein secreted by the liver, belonging to the angiopoietin-like family of eight proteins. …”
  20. 40

    Pathology of the liver in obese and diabetic ob/ob and db/db mice fed a standard or high-calorie diet by Nasser, Selim

    Published 2011
    “…Non-alcoholic fatty liver disease (NAFLD) is one of the commonest liver diseases in Western countries. …”
    Get full text
    Get full text
    Get full text
    Get full text
    article